LDS/Medical Tests/Succinate Dehydrogenase (SDHA, SDHB, SDHC and SDHD) Gene Mutation Analysis

Succinate Dehydrogenase (SDHA, SDHB, SDHC and SDHD) Gene Mutation Analysis

Succinate dehydrogenase is a complex enzyme important in linking the Krebs cycle with the electron transport chain. It is composed of four subunits (A, B, C, D) each coded for by distinct genes: SDHA, SDHB, SDHC and SDHD. Additionally, there are four ‘complex assembly factor’ proteins (1, 2, 3, 4) that are important for the assembly of the enzyme complex. These assembly factors are coded for by separate genes: SDHAF1, SDHAF2, SDHAF3 and SDHAF4. Multiple mutations in these genes, mostly missense and nonsense mutations, may result in pathogenic variants.

SDHA (5p15.33): This gene codes for a major catalytic subunit of succinate-ubiquinone oxidoreductase located on the inner membrane of mitochondria. Mutations in SDHA are associated with a mitochondrial respiratory chain deficiency termed Leigh Syndrome.

SDHB (1p36.13); This is a tumor suppressor gene that codes for the iron-sulfur protein subunit of SDH. Mutations in this gene are associated with the development of paragangliomas, pheochromocytoma, SDH-deficient gastrointestinal stromal tumors (GIST), SDH-deficient renal cell carcinoma and are implicated in nuclear type 4 mitochondrial complex II deficiency.

SDHC (1q23.3): This gene codes for one of four nuclear-encoded subunits of SDH. It is an integral mitochondrial membrane protein that anchors then other subunits forming a catalytic core. Mutations have been associated with paragangliomas.

SDHD (11q23.1): This gene encodes for a protein that is responsible for the oxidation of succinate and is also one of the integral membrane proteins anchoring the enzyme complex in the mitochondrial membrane. Mutations in SDHD are associated with hereditary paraganglioma. Interestingly, this disorder is transmitted almost exclusively through the paternal allele suggesting that the locus may be maternally imprinted.

SDHAF1 (19q13.12): This gene codes for a protein that is critical for the assembly of the SDH enzyme complex but is not itself part of the complex. Mutations in this gene are associated with SDH-defective infantile leukoencephalopathy.

SDHAF2 (11q12.2): This gene encodes for a protein required for the flavination of SDHA which is required for the function of SDH. Mutations of this gene are associated with paraganglioma.

SDHAF3 (7q21.3) and SDHAF4 (6q.13): These genes appear to be involved in SDH assembly; however, their exact function is unknown. Mutations in these genes have no known disease associations.

SDH mutations cause deficient SDH activity resulting to uncoordinated Krebs cycle and electron transport chain. Succinate accumulates in the cytoplasm which stimulates hypoxia pathways and causes epigenetic changes, including hypermethylation. Hypermethylation of tumor suppressor genes may result in tumorigenesis. Testing for mutations in these distinct genes may aid in the identification of the source of succinate dehydrogenase deficiency.

  • As an aid in the diagnosing the Hereditary Paraganglioma-Pheochromocytoma Syndrome
  • As an aid in the diagnosis of SDH-deficient renal cell carcinoma, and SADH-deficient gastrointestinal stromal tumors

A positive result indicates the presence of mutations in the SDHA, SDHB, SDHC, SDHD SDHAF1, and/or SDHAF2 genes.

A negative result indicates the absence of mutations in the SDHA, SDHB, SDHC, SDHD SDHAF1, and/or SDHAF2 genes. 

Negative for mutations analyzed (No mutation or pathogenic variant detected)

Next Generation Sequencing (NGS), Sanger sequencing.

Whole blood collected in EDTA (Lavender top tube).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: unstable
Succinate dehydrogenase activity colorimetric assay.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login